Ask AI
VERITAC 2
VERITAC-2: Phase III Study of Vepdegestrant vs Fulvestrant in Previously Treated ER-Positive/HER2-Negative Advanced Breast Cancer

Released: June 03, 2025

Expiration: December 02, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 03, 2025

Expiration: December 02, 2025